Author's Reply to Wendling and Prati: “Treat-to-Target in Spondyloarthritis: Implications for Clinical Trial Designs”

被引：0
|
作者：
James Cheng-Chung Wei
机构：
[1] Chung Shan Medical University,Institute of Medicine
[2] Chung Shan Medical University Hospital,Division of Allergy, Immunology and Rheumatology
[3] China Medical University,Graduate Institute of Integrated Medicine
来源：
Drugs | 2014年 / 74卷
关键词：
Ankylose Spondylitis; Inactive Disease; Bath Ankylose Spondylitis Functional Index; Moderate Disease Activity; Ankylose Spondylitis Disease Activity Score;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1717 / 1718
页数：1
相关论文
共 50 条
  • [31] THE VALUE OF ADDING MRI TO A CLINICAL TREAT-TO-TARGET STRATEGY IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION: CLINICAL AND RADIOGRAPHIC OUTCOMES FROM THE IMAGINE-RA RANDOMISED CONTROLLED TRIAL
    Moller-Bisgaard, S.
    Horslev-Pedersen, K.
    Ejbjerg, B.
    Hetland, M.
    Ornbjerg, L.
    Glinatsi, D.
    Moller, J.
    Boesen, M.
    Christensen, R.
    Stengaard-Pedersen, K.
    Madsen, O. R.
    Jensen, B.
    Villadsen, J.
    Hauge, E-M.
    Bennett, P.
    Hendricks, O.
    Asmussen, K.
    Kowalski, M.
    Lindegaard, H.
    Nielsen, S. M.
    Bliddal, H.
    Krogh, N.
    Ellingsen, T.
    Nielsen, A. H.
    Balding, L.
    Jurik, A. G.
    Thomsen, H.
    Ostergaard, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 58 - 59
  • [32] The Value of Adding MRI to a Clinical Treat-to-Target Strategy in Rheumatoid Arthritis Patients in Clinical Remission: Clinical and Radiographic Outcomes from the Imagine-RA Randomized Controlled Trial
    Moller-Bisgaard, Signe
    Horslev-Petersen, Kim
    Ejbjerg, Bo Jannik
    Hetland, Merete Lund
    Glinatsi, Daniel
    Ornbjerg, Lykke
    Moller, Jakob M.
    Boesen, Mikael
    Christensen, Robin
    Stengaard-Pedersen, Kristian
    Madsen, Ole Rintek
    Jensen, Bente
    Villadsen, Jan Alexander
    Hauge, Ellen-Margrethe
    Bennett, Philip
    Hendricks, Oliver
    Asmussen, Karsten
    Kowalski, Marcin Ryszard
    Lindegaard, Hanne
    Nielsen, Sabrina Mai
    Bliddal, Henning
    Krogh, Niels Steen
    Ellingsen, Torkell
    Nielsen, Agente
    Balding, Lone
    Jurik, Anne Grethe
    Thomsen, Henrik S.
    Ostergaard, Mikkel
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [33] Randomized clinical trial of laparoscopic cholecystectomy performed with mini-instruments - Author's reply
    Sarli, L
    BRITISH JOURNAL OF SURGERY, 2004, 91 (05) : 646 - 646
  • [34] Correspondence on "Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial" by Molto et al
    Kiltz, Uta
    Braun, Juergen
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (12) : E229 - E229
  • [35] Clinical management for small bowel of Crohn's disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesion
    Watanabe, Kenji
    INTESTINAL RESEARCH, 2020, 18 (04) : 347 - 354
  • [36] Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial
    van Dijk, Bastiaan T.
    Bergstra, Sytske Anne
    van den Berg, J. Merlijn
    Schonenberg-Meinema, Dieneke
    van Suijlekom-Smit, Lisette W. A.
    van Rossum, Marion A. J.
    Koopman-Keemink, Yvonne
    ten Cate, Rebecca
    Allaart, Cornelia F.
    Brinkman, Danielle M. C.
    Muller, Petra C. E. Hissink
    PEDIATRIC RHEUMATOLOGY, 2024, 22 (01)
  • [37] Aiming for Remission in Rheumatoid Arthritis: Clinical and Radiographic Outcomes from a Randomized Controlled Strategy Trial Investigating the Added Value of Ultrasonography in a Treat-to-Target Regimen
    Haavardsholm, Espen A.
    Aga, Anna-Birgitte
    Olsen, Inge C.
    Hammer, Hilde B.
    Uhlig, Till
    Fremstad, Hallvard
    Madland, Tor Magne
    Lexberg, Ase S.
    Haukeland, Hilde
    Rodevand, Erik
    Hoili, Christian
    Stray, Hilde
    Bendvold, Anne Noraas
    Hansen, Inger Johanne Widding
    Bakland, Gunnstein
    Nordberg, Lena B.
    Lillegraven, Siri
    van der Heijde, Desiree
    Kvien, Tore K.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [38] Response to: 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial'' by Cai and Peng response
    Molto, Anna
    van der Heijde, Desiree
    van den Bosch, Filip E.
    Dougados, Maxime
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (07)
  • [39] Anti-TNF de-escalation following a treat-to-target strategy with golimumab therapy intensification to reach continuous clinical response in ulcerative colitis: the In-Target GETAID trial
    Vuitton, L.
    Poullenot, F.
    Bouhnik, Y.
    Wils, P.
    Buisson, A.
    Viennot, S.
    Bouguen, G.
    Hebuterne, X.
    Gilletta, C.
    Nancey, S.
    Bourreille, A.
    Amil, M.
    Altwegg, R.
    Goutorbe, F.
    Caillo, L.
    Plastaras, L.
    Brixi, H.
    Simon, M.
    Serrero, M.
    Fumery, M.
    Rahier, J. F.
    Vicaut, E.
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1280 - I1280
  • [40] EFFICACY OF THE TREAT-TO-TARGET APPROACH IN MODIFYING DISEASE COURSE WITH USTEKINUMAB IN PATIENTS WITH MODERATETO-SEVERE CROHN'S DISEASE: RESULTS FROM THE STARDUST TRIAL
    Peyrin-Biroulet, Laurent
    Vermeire, Severine
    D'Haens, Geert R.
    Panes, Julian
    Dignass, Axel
    Magro, Fernando
    Le Bars, Manuela
    Lahaye, Marjolein
    Nazar, Maciej
    Ni, Lioudmila
    Bravata, Ivana
    Lavie, Frederic
    Daperno, Marco
    Lukas, Milan
    Armuzzi, Alessandro
    Lowenberg, Mark
    Gaya, Daniel R.
    Danese, Silvio
    GASTROENTEROLOGY, 2022, 162 (07) : S800 - S800
12345